Soleno Therapeutics, Inc. (SLNO)
NASDAQ: SLNO · Real-Time Price · USD
78.71
-2.48 (-3.05%)
Aug 7, 2025, 4:00 PM - Market closed
Soleno Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts that cover Soleno Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $110.22, which forecasts a 40.03% increase in the stock price over the next year. The lowest target is $74 and the highest is $145.
Price Target: $110.22 (+40.03%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Soleno Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Strong Buy Maintains $97 → $106 | Strong Buy | Maintains | $97 → $106 | +34.67% | Aug 7, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $105 → $110 | Buy | Maintains | $105 → $110 | +39.75% | Aug 7, 2025 |
| Baird | Baird | Buy Maintains $105 → $121 | Buy | Maintains | $105 → $121 | +53.73% | Jul 11, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $81 → $97 | Strong Buy | Maintains | $81 → $97 | +23.24% | May 8, 2025 |
| Baird | Baird | Buy Maintains $102 → $105 | Buy | Maintains | $102 → $105 | +33.40% | May 8, 2025 |
Financial Forecast
Revenue This Year
111.45M
Revenue Next Year
344.73M
from 111.45M
Increased by 209.31%
EPS This Year
-3.20
from -4.38
EPS Next Year
1.24
from -3.20
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 176.4M | 574.7M | 900.9M |
| Avg | 111.5M | 344.7M | 629.2M |
| Low | 23.1M | 225.9M | 424.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 415.6% | 161.3% |
| Avg | - | 209.3% | 82.5% |
| Low | - | 102.7% | 23.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.68 | 2.91 | 7.58 |
| Avg | -3.20 | 1.24 | 5.37 |
| Low | -3.51 | 0.08 | 2.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 512.3% |
| Avg | - | - | 334.1% |
| Low | - | - | 88.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.